The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C

Background: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. This study aimed to assess the impact of IFNL4 rs368234815 polymorphism on treatment response to pegylated-IFN alpha (Peg-IFN-α)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maryam Keshvari, Seyed Moayed Alavian, Bita Behnava, Ali Pouryasin, Heidar Sharafi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2016-01-01
coleção:	Journal of Research in Medical Sciences
Assuntos:	Genetic polymorphism hepatitis C human interferon lambda 4 protein
Acesso em linha:	http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2016;volume=21;issue=1;spage=72;epage=72;aulast=Keshvari
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!